About Universitätsklinikum Freiburg; Chirurgische Klinik; Abteilung Urologie
Clinical Trials at Universitätsklinikum Freiburg; Chirurgische Klinik; Abteilung Urologie
During the past decade, Universitätsklinikum Freiburg; Chirurgische Klinik; Abteilung Urologie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on
average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Freiburg; Chirurgische Klinik; Abteilung Urologie"
#1 collaborator was "Chugai" with 1 trials as a collaborator and "Exelixis" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Universitätsklinikum Freiburg; Chirurgische Klinik; Abteilung Urologie
According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Freiburg; Chirurgische Klinik; Abteilung Urologie" are
"Bladder Cancer" (3 trials), "Carcinoma, Renal Cell" (1 trials), "Hormonal Refractory Prostate Cancer" (1 trials), "Peyronie's Disease" (1 trials) and "Prostatic Neoplasms, Castration-Resistant" (1 trials). Many other conditions were trialed in "Universitätsklinikum Freiburg; Chirurgische Klinik; Abteilung Urologie" in a lesser frequency.
Clinical Trials Intervention Types at Universitätsklinikum Freiburg; Chirurgische Klinik; Abteilung Urologie
Most popular intervention types in "Universitätsklinikum Freiburg; Chirurgische Klinik; Abteilung Urologie" are "Drug" (6 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (4 trials), "AA4500" (1 trials), "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials), "CV9103" (1 trials) and "Cabozantinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Universitätsklinikum Freiburg; Chirurgische Klinik; Abteilung Urologie
The vast majority of trials in "Universitätsklinikum Freiburg; Chirurgische Klinik; Abteilung Urologie" are
5 trials for "All" genders and 3 trials for "Male" genders.
Clinical Trials Status at Universitätsklinikum Freiburg; Chirurgische Klinik; Abteilung Urologie
Currently, there are NaN active trials in "Universitätsklinikum Freiburg; Chirurgische Klinik; Abteilung Urologie".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Universitätsklinikum Freiburg; Chirurgische Klinik; Abteilung Urologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Universitätsklinikum Freiburg; Chirurgische Klinik; Abteilung Urologie, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".